Enlivex Therapeutics Ltd. ENLV

ENLV Quotes by TradingView
Institutional shares held 3.41 Million
11.8K calls
9.1K puts
Total value of holdings $3.52M
$12K calls
$9K puts
Market Cap $19M
18,403,200 Shares Out.
Institutional ownership 18.56%
# of Institutions 27

Quarterly Institutional Activity in ENLV

Shares Bought
Shares Sold
View Transactions

Top Institutions Holding ENLV

View all
View all

Latest Institutional Activity in ENLV

Top Purchases

Q4 2024
Millennium Management LLC Shares Held: 634K ($653K)
634K Shares purchased
New Holding
Q4 2024
Renaissance Technologies LLC Shares Held: 159K ($164K)
84.2K Shares purchased
112.59% Added
Q4 2024
Armistice Capital, LLC Shares Held: 2.21M ($2.27M)
69K Shares purchased
3.23% Added
Q4 2024
Morgan Stanley Shares Held: 270K ($278K)
23.9K Shares purchased
9.73% Added
Q4 2024
Two Sigma Securities, LLC Shares Held: 22.4K ($23K)
22.4K Shares purchased
New Holding
View All Buyers

Top Sells

Q4 2024
Ubs Group Ag Shares Held: 16 ($16.5)
3.2K Shares sold
99.5% Reduced
Q4 2024
Sigma Investment Counselors Inc Shares Held: 28K ($28.8K)
2K Shares sold
6.67% Reduced
Q4 2024
Steward Partners Investment Advisory, LLC Shares Held: 2.5K ($2.58K)
500 Shares sold
16.67% Reduced
Q3 2024
Xtx Topco LTD Shares Held: 22.7K ($23.3K)
2.16K Shares sold
8.71% Reduced
Q3 2024
Group One Trading, L.P. Shares Held: 5.73K ($5.9K)
19 Shares sold
0.33% Reduced
View All Sellers

About ENLV

Enlivex Therapeutics Ltd. operates as a clinical-stage macrophage reprogramming immunotherapy company. It is developing Allocetra, a cell-based therapy to treat organ dysfunction and failure associated with sepsis that is in phase II clinical trial, as well as in preclinical trial to treat solid tumors. Enlivex Therapeutics Ltd. was founded in 2005 and is headquartered in Nes Ziona, Israel.

ENLV Chart by TradingView
ENLV Fundamental Data by TradingView

Insider Transactions at ENLV

Insider Transaction List

View all
Date Insider Transaction Ownership Type Shares Traded Value / Price
View All Transactions

Last 12 Months Summary

Buy / Acquisition
0 Shares
From 0 Insiders
Sell / Disposition
0 Shares
From 0 Insiders

Track Institutional and Insider Activities on ENLV

Follow Enlivex Therapeutics Ltd. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells ENLV shares.

Notify only if
Any

Insider Trading

Get notified when an Enlivex Therapeutics Ltd. insider buys or sells ENLV shares.

Notify only if
Any
Any
P - Open market or private purchase×
S - Open market or private sale×
V - Transaction voluntarily reported earlier than required×
A - Grant, award, or other acquisition×
D - Sale (or disposition) back to the issuer×
F - Payment of exercise price or tax liability×
I - Discretionary transaction×
M - Exercise of conversion of derivative security×
C - Conversion of derivative security×
E - Expiration of short derivative position×
H - Expiration (or cancellation) of long derivative position with value received×
O - Exercise of out-of-the-money derivative securities×
X - Exercise of in-the-money or at-the-money derivatives securities×
G - Bona fide gift×
L - Small Acquisition×
W - Acquisition or disposition by will or laws×
Z - Deposit into or withdrawal from voting trust×
J - Other acquisition or disposition×
K - Transaction in equity swap or similar instrument×
U - Disposition due to a tender of shares in a change of control transaction×
20 item(s) selected

News

Receive news related to Enlivex Therapeutics Ltd.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on ENLV